This study may be true, but I wonder. The side effects can be horrendous and do affect people differently so be sure that you are aware of all of them before taking. This study promotes it a 'Best Result Ever' when used with Lantus for Type 2 diabetes.
One of the more serious side effects is that it overworks an already in trouble pancreas and can cause pancreatitis (inflammation of the pancreas). This is just one of the side effects and people have not had any problems with this. Then you add nausea, vomiting, and diarrhea and the side effects can be very unpleasant.
The other benefit is exenatide (Byetta) does promote weight loss and for some people this is a good thing. When used with Lantus, there appears to be some good benefits in that hypoglycemia is generally not a problem. Yes, it can happen if you are careless and overdose with either.
With this being an interesting study, I question why it was only 30 weeks and only used 261 participants in five countries. This has been published in the Annals of Internal Medicine on December 7, 2010. You may read it here.
The study was funded and sponsored by an alliance of Eli Lilly and Company and Amylin Pharmaceuticals, who are collaborating to market Byetta, and they have the most to gain from this study. This is another reason I question the value of the study.
No comments:
Post a Comment